jRCT1050220190尚未招募不适用
Effects of SGLT2 inhibitors on appetite in patients with type 2 diabetes
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 58
- 主要终点
- Mean difference in fasting plasma glucose
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20age old over 至 85age old not（—）
- 性别
- All
入选标准
- •Those with a diagnosis of type 2 diabetes
- •Persons starting SGLT2 inhibitors
- •Patients between 20 and 85 years of age
- •Patients with renal function eGFR 30 or higher
- •BMI of 18.5 or more
排除标准
- •Those undergoing treatment for cancer
- •Pregnant women
- •Those who are emotionally unstable due to mental illness, etc. and have difficulty participating in the research
- •Those who have difficulty in reading and understanding Japanese
- •Persons with dementia
- •Those who are judged by the attending physician or researcher to be unable to participate in the research.
结局指标
主要结局
Mean difference in fasting plasma glucose
时间窗: 24 weeks
Mean difference in fasting plasma glucose at 24 weeks and at the start of SGLT2 inhibitor
Mean difference in total score on the Japanese version of the Power of Food Scale
时间窗: 24 weeks
Mean difference in total score on the Japanese version of the Power of Food Scale between the start of SGLT2 inhibitor and the 24-week time point
次要结局
- Mean difference in HbA1c(24 weeks)
- Mean difference in daily carbohydrate intake(24 weeks)
- Mean difference in body weight(24 weeks)
- Difference in ketone body fraction(24 weeks)
- Mean difference in calorie intake per day(24 weeks)
- Mean difference in lipid intake per day(24 weeks)
- Mean difference in the total score of the Food Craving Inventory for Japanese psychological scale(24 weeks)
- Mean difference in protein intake per day(24 weeks)
- Free response on change in dietary habits(24 weeks)
研究者
相似试验
尚未招募
Unknown
Effects of SGLT2 inhibitors on appetite in patients with type 2 diabetesJPRN-jRCT1050220190in Kazuko58
进行中（未招募）
1 期
SEESAW (SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation)Type 2 diabetes mellitusMedDRA version: 21.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2015-001594-40-GBniversity of Leicester76
已完成
4 期
The effects of empagliflozin on appetite and weight regulation in diabeticsDiabetes mellitusSpecialty: Diabetes, Primary sub-specialty: BothUKCRC code/ Disease: Metabolic/ Diabetes mellitus, Metabolic/ Diabetes mellitusNutritional, Metabolic, EndocrineISRCTN82062639niversity of Leicester68
已完成
不适用
Efficacy and change in taste by taking SGLT2 inhibitor in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000020157agasaki University Hospital60
已完成
不适用
Effect of SGLT2 inhibitor on energy metabolism in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000024822Kyoto University Graduate School of Medicine100